Global Alpha and Beta Emitters Based Radiopharmaceuticals Market
Description
The global alpha and beta emitters based radiopharmaceuticals market is expected to reach USD 1,769.20 million by 2032 from USD 801.45 million in 2024, growing with a substantial CAGR of 10.4% in the forecast period of 2025 to 2032.
Market Segmentation:
Global Alpha and Beta Emitters Based Radiopharmaceuticals Market, By Isotope (Beta Emitters and Alpha Emitters), Sources (Reactor-Produced Isotopes, Generator-Produced Isotopes, and Others), Therapeutic Application (Oncology and Others), Vector Type (Small Molecule Ligands, Peptides, Monoclonal Antibodies, and Others), End User (Hospitals, Radiopharmacies, and Research Institutes), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Russia, Turkey, Netherlands, Poland, Norway, Austria, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Peru, Chile, Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Kuwait, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2032
Overview of Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Dynamics:
Driver
• Increased efficacy of targeted alpha and beta therapies
• Growing adoption of theranostics in personalized medicine
• Rising clinical demand for alpha-based radiotherapies
Restraints
• Supply chain and scalability challenges from short isotope half-lives
• Stringent regulatory landscape limiting market flexibility
Opportunities
• Surge in R&D activity expanding radiopharmaceutical applications
• Expansion of Lu-177-PSMA therapy in prostate cancer treatment
Market Players:
The key players operating in the global alpha and beta emitters based radiopharmaceuticals market are:
• Novartis AG
• Eckert & Ziegler
• ITM Isotope Technologies Munich SE
• SHINE Technologies, LLC
• Actinium Pharmaceuticals, Inc.
• Alpha Tau Medical Ltd.
• ARICEUM THERAPEUTICS
• Bayer AG
• Curium
• IONETIX Corporation
• Isotopia
• Lantheus
• Lilly
• Niowave
• NMR
• Oncoinvent
• Orano Group
• Radiopharm Theranostics Limited
• Telix Pharmaceuticals Limited
• Terthera
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Market Segmentation:
Global Alpha and Beta Emitters Based Radiopharmaceuticals Market, By Isotope (Beta Emitters and Alpha Emitters), Sources (Reactor-Produced Isotopes, Generator-Produced Isotopes, and Others), Therapeutic Application (Oncology and Others), Vector Type (Small Molecule Ligands, Peptides, Monoclonal Antibodies, and Others), End User (Hospitals, Radiopharmacies, and Research Institutes), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Russia, Turkey, Netherlands, Poland, Norway, Austria, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Peru, Chile, Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Kuwait, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2032
Overview of Global Alpha and Beta Emitters Based Radiopharmaceuticals Market Dynamics:
Driver
• Increased efficacy of targeted alpha and beta therapies
• Growing adoption of theranostics in personalized medicine
• Rising clinical demand for alpha-based radiotherapies
Restraints
• Supply chain and scalability challenges from short isotope half-lives
• Stringent regulatory landscape limiting market flexibility
Opportunities
• Surge in R&D activity expanding radiopharmaceutical applications
• Expansion of Lu-177-PSMA therapy in prostate cancer treatment
Market Players:
The key players operating in the global alpha and beta emitters based radiopharmaceuticals market are:
• Novartis AG
• Eckert & Ziegler
• ITM Isotope Technologies Munich SE
• SHINE Technologies, LLC
• Actinium Pharmaceuticals, Inc.
• Alpha Tau Medical Ltd.
• ARICEUM THERAPEUTICS
• Bayer AG
• Curium
• IONETIX Corporation
• Isotopia
• Lantheus
• Lilly
• Niowave
• NMR
• Oncoinvent
• Orano Group
• Radiopharm Theranostics Limited
• Telix Pharmaceuticals Limited
• Terthera
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
350 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Global Alpha And Beta Emitters Based Radiopharmaceuticals Market
- 1.4 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Primary Interviews With Key Opinion Leaders
- 2.8 Dbmr Market Position Grid
- 2.9 Vendor Share Analysis
- 2.10 End User Market Coverage Grid
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 4.3 Pipeline
- 4.4 Supply Chain Ecosystem
- 4.4.1 Prominent Companies
- 4.4.2 Small & Medium Size Companies
- 4.4.3 End Users
- 4.5 Industry Insights:
- 4.5.1 Micro And Macro Economic Factors
- 4.5.2 Key Pricing Strategies
- 4.6 Marketed Drug Analysis
- 4.6.1 Drug
- 4.6.1.1 Brand Name
- 4.6.1.2 Generic Name
- 4.6.2 Therapeutic Indication
- 4.6.3 Pharmacological Class Of The Drug
- 4.6.4 Drug Primary Indication
- 4.6.5 Market Status
- 4.6.6 Medication Type
- 4.6.7 Drug Dosage Form
- 4.6.8 Dosages Availability
- 4.6.9 Packaging Type
- 4.6.10 Drug Route Of Administration
- 4.6.11 Dosing Frequency
- 4.6.12 Drug Insight
- 4.6.13 Overview Of Drug Development Activities
- 4.6.13.1 Forecast Market Outlook
- 4.6.13.2 Cross Competition
- 4.6.13.3 Therapeutic Portfolio
- 4.6.13.4 Current Development Scenario
- 4.7 Healthcare Tariffs Impact Analysis
- 4.7.1 Overview
- 4.7.2 Tariff Structures
- 4.7.2.1 Global Vs. Regional Tariff Structures
- 4.7.2.2 United States: Medicare/Medicaid Tariff Policies, Cms Pricing Models
- 4.7.2.3 European Union: Cross-border Tariff Regulations, Reimbursement Policies
- 4.7.2.4 Asia-pacific: Government-imposed Tariffs On Imported Medical Products
- 4.7.2.5 Emerging Markets: Challenges In Tariff Implementation
- 4.7.3 Pharmaceutical Tariffs And Trade Barriers
- 4.7.3.1 Import Duties On Prescription Drugs Vs. Generics
- 4.7.3.2 Impact On Drug Affordability And Access
- 4.7.3.3 Key Trade Agreements Affecting Pharmaceutical Tariffs
- 4.8 Impact Of Healthcare Tariffs On Providers And Patients
- 4.8.1.1 Cost Burden On Hospitals And Healthcare Facilities
- 4.8.1.2 Effect On Patient Affordability And Insurance Coverage
- 4.8.1.3 Tariffs And Their Role In Medical Tourism
- 4.8.2 Trade Agreements And Healthcare Tariffs
- 4.8.2.1 Wto Regulations On Healthcare Tariffs
- 4.8.2.2 Impact Of Trade Wars On The Healthcare Supply Chain
- 4.8.2.3 Role Of Free Trade Agreements (Ftas) In Reducing Tariffs
- 4.8.3 Impact Of Tariffs On Healthcare Costs And Accessibility
- 4.8.4 Importance Of Tariffs In The Healthcare Sector
- 4.9 Epidemiology Overview
- 4.9.1 Incidence Of All Cancers By Gender
- 4.9.2 Treatment Rate
- 4.9.3 Mortality Rate
- 4.9.4 Drug Adherence And Therapy Switch Model
- 4.9.5 Patient Treatment Success Rates
- 5 Regulatory Framework
- 5.1 Regulatory Framework Overview For The North America Alpha And Beta Emitters Based Radiopharmaceuticals Market
- 5.1.1 Geographies’ Ease Of Regulatory Approval
- 5.1.2 Regulatory Approval Pathways
- 5.1.3 Licensing And Registration
- 5.1.4 Post-marketing Surveillance
- 5.1.5 Good Manufacturing Practices (Gmps) Guidelines
- 5.2 Regulatory Framework Overview For The South America Alpha And Beta Emitters Based Radiopharmaceuticals Market
- 5.2.1 Geographies’ Ease Of Regulatory Approval
- 5.2.2 Regulatory Approval Pathways
- 5.2.3 Licensing And Registration
- 5.2.4 Post-marketing Surveillance
- 5.2.5 Good Manufacturing Practices (Gmps) Guidelines
- 5.3 Regulatory Framework Overview For The Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market
- 5.3.1 Geographies’ Ease Of Regulatory Approval
- 5.3.2 Regulatory Approval Pathways
- 5.3.3 Licensing And Registration
- 5.3.4 Post-marketing Surveillance
- 5.3.5 Good Manufacturing Practices (Gmps) Guidelines
- 5.4 Regulatory Framework Overview For The Asia-pacific Alpha And Beta Emitters Based Radiopharmaceuticals Market
- 5.4.1 Geographies’ Ease Of Regulatory Approval
- 5.4.2 Regulatory Approval Pathways
- 5.4.3 Licensing And Registration
- 5.4.4 Post-marketing Surveillance
- 5.4.5 Good Manufacturing Practices (Gmps) Guidelines
- 5.5 Regulatory Framework Overview For The Middle East And Africa Alpha And Beta Emitters Based Radiopharmaceuticals Market
- 5.5.1 Geographies’ Ease Of Regulatory Approval
- 5.5.2 Regulatory Approval Pathways
- 5.5.3 Licensing And Registration
- 5.5.4 Post-marketing Surveillance
- 5.5.5 Good Manufacturing Practices (Gmps) Guidelines
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increased Efficacy Of Targeted Alpha And Beta Therapies
- 6.1.2 Growing Adoption Of Theranostics In Personalized Medicine
- 6.1.3 Rising Clinical Demand For Alpha-based Radiotherapies
- 6.1.4 Rising Chronic Disease Burden Driving Radiopharmaceutical Demand
- 6.2 Restraints
- 6.2.1 Supply Chain And Scalability Challenges From Short Isotope Half-lives
- 6.2.2 Stringent Regulatory Landscape Limiting Market Flexibility
- 6.2.3 Safety And Exposure Risks In Radiopharmaceutical Use
- 6.3 Opportunities
- 6.3.1 Surge In R&D Activity Expanding Radiopharmaceutical Applications
- 6.3.2 Expansion Of Lu-177-psma Therapy In Prostate Cancer Treatment
- 6.3.3 Strategic Collaborations Driving Radiopharmaceutical Innovation
- 6.4 Challenges
- 6.4.1 High Cost Of Development And Implementation Of Radiopharmaceuticals
- 6.4.2 Shortage Of Skilled Workforce In Nuclear Medicine And Radiochemistry
- 7 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope
- 7.1 Overview
- 7.2 Beta Emitters
- 7.2.1 Lutetium-177
- 7.2.2 Terbium-161
- 7.3 Alpha Emitters
- 7.3.1 Actinium-225
- 7.3.2 Lead -212
- 8 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources
- 8.1 Overview
- 8.2 Reactor-produced Isotopes
- 8.3 Generator-produced Isotopes
- 8.4 Others
- 9 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application
- 9.1 Overview
- 9.2 Oncology
- 9.2.1 Prostate Cancer
- 9.2.2 Neuroendocrine Tumors
- 9.2.3 Liver Cancer
- 9.2.4 Brain Tumors
- 9.2.5 Breast Cancer
- 9.2.6 Leukemia
- 9.3 Others
- 10 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type
- 10.1 Overview
- 10.2 Small Molecule Ligands
- 10.3 Peptides
- 10.4 Monoclonal Antibodies
- 10.5 Others
- 11 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User
- 11.1 Overview
- 11.2 Hospitals
- 11.2.1 Oncology Centers
- 11.2.2 Nuclear Medicine Departments
- 11.3 Radiopharmacies
- 11.4 Research Institutes
- 12 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region
- 12.1 Overview
- 12.2 North America
- 12.2.1 U.S.
- 12.2.2 Canada
- 12.2.3 Mexico
- 12.3 Europe
- 12.3.1 Germany
- 12.3.2 U.K.
- 12.3.3 France
- 12.3.4 Italy
- 12.3.5 Spain
- 12.3.6 Poland
- 12.3.7 Russia
- 12.3.8 Norway
- 12.3.9 Turkey
- 12.3.10 Austria
- 12.3.11 Ireland
- 12.3.12 Netherlands
- 12.3.13 Switzerland
- 12.3.14 Rest Of Europe
- 12.4 Asia Pacific
- 12.4.1 China
- 12.4.2 Australia
- 12.4.3 Japan
- 12.4.4 South Korea
- 12.4.5 Singapore
- 12.4.6 India
- 12.4.7 Indonesia
- 12.4.8 Philippines
- 12.4.9 Thailand
- 12.4.10 Malaysia
- 12.4.11 Vietnam
- 12.4.12 Taiwan
- 12.4.13 Rest Of Asia-pacific
- 12.5 South America
- 12.5.1 Brazil
- 12.5.2 Argentina
- 12.5.3 Chile
- 12.5.4 Peru
- 12.5.5 Rest Of South America
- 12.6 Middle East And Africa
- 12.6.1 South Africa
- 12.6.2 Egypt
- 12.6.3 Saudi Arabia
- 12.6.4 U.A.E.
- 12.6.5 Kuwait
- 12.6.6 Israel
- 12.6.7 Rest Of Middle East And Africa
- 13 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Company Landscape
- 13.1 Company Share Analysis: Global
- 13.2 Company Share Analysis: Asia-pacific
- 13.3 Company Share Analysis: Europe
- 13.4 Company Share Analysis: North America
- 14 Swot Analysis
- 15 Company Profiles
- 15.1 Novartis Ag
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Company Share Analysis
- 15.1.4 Product Portfolio
- 15.1.5 Recent Developments
- 15.2 Eckert & Ziegler
- 15.2.1 Company Snapshot
- 15.2.2 Revenue Analysis
- 15.2.3 Company Share Analysis
- 15.2.4 Product Portfolio
- 15.2.5 Recent Developments
- 15.3 Itm Isotope Technologies Munich Se
- 15.3.1 Company Snapshot
- 15.3.2 Company Share Analysis
- 15.3.3 Product Portfolio
- 15.3.4 Recent Development
- 15.4 Shine Technologies, Llc
- 15.4.1 Company Snapshot
- 15.4.2 Company Share Analysis
- 15.4.3 Product Portfolio
- 15.4.4 Recent Development
- 15.5 Actinium Pharmaceuticals, Inc.
- 15.5.1 Company Snapshot
- 15.5.2 Pipeline Product Portfolio
- 15.5.3 Recent Developments
- 15.6 Alpha Tau Medical Ltd.
- 15.6.1 Company Snapshot
- 15.6.2 Pipeline Product Portfolio
- 15.6.3 Recent Development
- 15.7 Ariceum Therapeutics
- 15.7.1 Company Snapshot
- 15.7.2 Pipeline Product Portfolio
- 15.7.3 Recent Development
- 15.8 Bayer Ag
- 15.8.1 Company Snapshot
- 15.8.2 Revenue Analysis
- 15.8.3 Pipeline Product Portfolio
- 15.8.4 Recent Development
- 15.9 Curium
- 15.9.1 Company Snapshot
- 15.9.2 Pipeline Product Portfolio
- 15.9.3 Recent Development
- 15.10 Ionetix Corporation
- 15.10.1 Company Snapshot
- 15.10.2 Pipeline Product Portfolio
- 15.10.3 Recent Development
- 15.11 Isotopia
- 15.11.1 Company Snapshot
- 15.11.2 Pipeline Product Portfolio
- 15.11.3 Recent Development
- 15.12 Lantheus
- 15.12.1 Company Snapshot
- 15.12.2 Revenue Analysis
- 15.12.3 Pipeline Product Portfolio
- 15.12.4 Recent Development
- 15.13 Lilly
- 15.13.1 Company Snapshot
- 15.13.2 Revenue Analysis
- 15.13.3 Pipeline Product Portfolio
- 15.14 Niowave
- 15.14.1 Company Snapshot
- 15.14.2 Pipeline Product Portfolio
- 15.14.3 Recent Development
- 15.15 Nmr
- 15.15.1 Company Snapshot
- 15.15.2 Pipeline Product Portfolio
- 15.15.3 Recent Development
- 15.16 Oncoinvent
- 15.16.1 Company Snapshot
- 15.16.2 Pipeline Product Portfolio
- 15.16.3 Recent Development
- 15.17 Orano Group
- 15.17.1 Company Snapshot
- 15.17.2 Revenue Analysis
- 15.17.3 Pipeline Product Portfolio
- 15.17.4 Recent Development
- 15.18 Radiopharm Theranostics Limited
- 15.18.1 Company Snapshot
- 15.18.2 Pipeline Product Portfolio
- 15.18.3 Recent Development
- 15.19 Telix Pharmaceuticals Limited
- 15.19.1 Company Snapshot
- 15.19.2 Revenue Analysis
- 15.19.3 Pipeline Product Portfolio
- 15.19.4 Recent Development
- 15.20 Terthera
- 15.20.1 Company Snapshot
- 15.20.2 Pipeline Product Portfolio
- 15.20.3 Recent Development
- 15.20.4 Recent Development
- 16 Questionnaire
- 17 Related Reports
- List Of Tables
- Table 1 Global Clinical Trial Market For Global Alpha And Beta Emitters Based Radiopharmaceuticals Market
- Table 2 Distribution Of Products And Projects By Phase Global Alpha And Beta Emitters Based Radiopharmaceuticals Market
- Table 3 Distribution Of Projects By Therapeutic Area And Phase Global Alpha And Beta Emitters Based Radiopharmaceuticals Market
- Table 4 Distribution Of Projects By Scientific Approach And Phase Global Alpha And Beta Emitters Based Radiopharmaceuticals Market
- Table 5 Penetration And Growth Prospect Mapping
- Table 6 Incidence Of Cancer By Gender
- Table 7 Cancer Mortality Rate
- Table 8 Cancer Treatment Success Rate
- Table 9 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 10 Global Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 11 Global Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 12 Global Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 13 Global Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 14 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 15 Global Reactor-produced Isotopes In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 16 Global Generator-produced Isotopes In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 17 Global Others In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 18 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 19 Global Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 20 Global Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 21 Global Others In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 22 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 23 Global Small Molecule Ligands In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 24 Global Peptides In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 25 Global Monoclonal Antibodies In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 26 Global Others In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 27 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 28 Global Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 29 Global Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 30 Global Radiopharmacies In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 31 Global Research Institutes In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 32 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Region, 2018-2032 (Usd Thousand)
- Table 33 North America Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Country, 2018-2032 (Usd Thousand)
- Table 34 North America Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 35 North America Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 36 North America Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 37 North America Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 38 North America Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 39 North America Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 40 North America Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 41 North America Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 42 North America Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 43 U.S. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 44 U.S. Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 45 U.S. Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 46 U.S. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 47 U.S. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 48 U.S. Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 49 U.S. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 50 U.S. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 51 U.S. Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 52 Canada Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 53 Canada Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 54 Canada Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 55 Canada Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 56 Canada Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 57 Canada Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 58 Canada Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 59 Canada Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 60 Canada Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 61 Mexico Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 62 Mexico Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 63 Mexico Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 64 Mexico Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 65 Mexico Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 66 Mexico Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 67 Mexico Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 68 Mexico Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 69 Mexico Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 70 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Country, 2018-2032 (Usd Thousand)
- Table 71 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 72 Europe Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 73 Europe Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 74 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 75 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 76 Europe Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 77 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 78 Europe Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 79 Europe Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 80 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 81 Germany Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 82 Germany Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 83 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 84 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 85 Germany Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 86 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 87 Germany Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 88 Germany Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 89 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 90 U.K. Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 91 U.K. Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 92 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 93 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 94 U.K. Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 95 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 96 U.K. Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 97 U.K. Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 98 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 99 France Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 100 France Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 101 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 102 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 103 France Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 104 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 105 France Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 106 France Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 107 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 108 Italy Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 109 Italy Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 110 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 111 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 112 Italy Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 113 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 114 Italy Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 115 Italy Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 116 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 117 Spain Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 118 Spain Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 119 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 120 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 121 Spain Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 122 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 123 Spain Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 124 Spain Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 125 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 126 Poland Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 127 Poland Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 128 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 129 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 130 Poland Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 131 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 132 Poland Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 133 Poland Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 134 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 135 Russia Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 136 Russia Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 137 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 138 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 139 Russia Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 140 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- Table 141 Russia Alpha And Beta Emitters Based Radiopharmaceuticals Market, By End User, 2018-2032 (Usd Thousand)
- Table 142 Russia Hospitals In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 143 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Isotope, 2018-2032 (Usd Thousand)
- Table 144 Norway Beta Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 145 Norway Alpha Emitters In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 146 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Sources, 2018-2032 (Usd Thousand)
- Table 147 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Therapeutic Application, 2018-2032 (Usd Thousand)
- Table 148 Norway Oncology In Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Type, 2018-2032 (Usd Thousand)
- Table 149 Norway Alpha And Beta Emitters Based Radiopharmaceuticals Market, By Vector Type, 2018-2032 (Usd Thousand)
- List Of Figures
- Figure 1 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Segmentation
- Figure 2 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Data Triangulation
- Figure 3 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Droc Analysis
- Figure 4 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Global Vs Regional Market Analysis
- Figure 5 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Company Research Analysis
- Figure 6 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Multivariate Modelling
- Figure 7 Curve Line Chart, By Isotope
- Figure 8 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Interview Demographics
- Figure 9 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Dbmr Market Position Grid
- Figure 10 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Vendor Share Analysis
- Figure 11 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: End User Market Coverage Grid
- Figure 12 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Segmentation
- Figure 13 Global Alpha And Beta Emitters Based Radiopharmaceuticals Market: Executive Summary
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
